Two-phase liquid culture system models normal human adult erythropoiesis at the molecular level

European Journal of Haematology

Volumn 64, Issue 5, 2000, Pages 292-303

  Pope, Sharon H ^a   Fibach, Eitan ^b   Sun, Jun ^a   Chin, Kyung ^a   Rodgers, Griffin P ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Erythropoiesis; Gene expression; Globins; Transcription factors

Indexed keywords

ALPHA GLOBIN; BETA GLOBIN; CYTOKINE RECEPTOR; ERYTHROID KRUPPEL LIKE FACTOR; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; GAMMA GLOBIN; GROWTH FACTOR; MESSENGER RNA; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR SP1;

ADULT; ARTICLE; CELL CULTURE; CELL MATURATION; CONTROLLED STUDY; CULTURE MEDIUM; ERYTHROID CELL; ERYTHROPOIESIS; GENE EXPRESSION; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; APOPTOSIS; CELL CULTURE TECHNIQUES; ERYTHROCYTES; ERYTHROPOIESIS; ERYTHROPOIETIN; GENE EXPRESSION; GENE EXPRESSION REGULATION; GLOBINS; HUMANS; IN SITU NICK-END LABELING; LYMPHOCYTES; MODELS, GENETIC; RECEPTORS, CYTOKINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELLS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0034066115     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2000.90032.x     Document Type: Article

References (49)

1. 1. JANDL JH, MINOT GR. Blood. Testbook of Hematology. Boston/Toronto: Little, Brown and Company, 1987.
2. 2. BARON MH. Transcriptional control of globin gene switching during vertebrate development. Biochim Biophys Acta 1997;1351:51-72.
3. 3. BUNGERT J, ENGEL JD. The role of transcription factors in erythroid development. Ann Med 1996;28:47-55.
4. 4. SHIVDASANI RA, ORKIN SH. The transcriptional control of hematopoiesis [see comments]. Blood 1996;87:4025-4039.
5. 5. WIJGERDE M, GROSVELD F, FRASER P. Transcription complex stability and chromatin dynamics in vivo. Nature 1995;377: 209-213.
6. 6. MARIN M, KARIS A, VISSER P, GROSVELD F, PHILIPSEN S. Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation. Cell 1997;89:619-628.
7. 7. ELLIS J, TAN-UN KC, HARPER A, et al. A dominant chromatin-opening activity in 5′ hypersensitive site 3 of the human beta-globin locus control region. Embo J 1996; 15:562-568.
8. 8. PONDEL MD, MURPHY S, PEARSON L, CRADDOCK C, PROUDFOOT NJ. Sp1 functions in a chromatin-dependent manner to augment human alpha-globin promoter activity. Proc Natl Acad Sci USA 1995;92:7237-7241.
9. 9. PHILIPSEN S, PRUZINA S, GROSVELD F. The minimal requirements for activtiy in transgenic mice of hypersensitive site 3 of the Beta-globin locus control region. EMBO 1993;12: 1077-1085.
10. 10. GREGORY RC, TAXMAN DJ, SESHASAYEE D, KENSINGER MH, BIEKER JJ, WOJCHOWSKI DM. Functional interaction of GATA1 with erythroid Kruppel-like factor and Sp1 at defined erythroid promoters. Blood 1996;87:1793-1801.
11. 11. MERIKA M, ORKIN SH. Functional synergy and physical interactions of the erythroid transcription factor GATA-1 with the Kruppel family proteins Sp1 and EKLF. Mol Cell Biol 1995;15:2437-2447.
12. 12. FISCHER K-D, HAESE A, NOWOCK J. Cooperation of GATA-1 and Sp1 can result in synergistic transcriptional activation or interference. J Biol Chem 1993;268:23915-23923.
13. 13. NUEZ B, MICHALOVICH D, BYGRAVE A, PLOEMACHER R, GROSVELD F. Defective haematopoiesis in fetal liver resulting from inactivation of the EKLF gene. Nature 1995;375:316-318.
14. 14. WIJGERDE M, GRIBNAU J, TRIMBORN T, et al. The role of EKLF in human beta-globin gene competition. Genes Dev 1996;10:2894-2902.
15. 15. LI Q, CLEGG C, PETERSON K, SHAW S, RAICH N, STAMATOYANNOPOULOS G. Binary transgenic mouse model for studying the trans control of globin gene switching: evidence that GATA-1 is an in vivo represser of human epsilon gene expression. Proc Natl Acad Sci USA 1997; 94:2444-2448.
16. 16. PERKINS AC, GAENSLER KM, ORKIN SH. Silencing of human fetal globin expression is impaired in the absence of the adult beta-globin gene activator protein EKLF. Proc Natl Acad Sci USA 1996;93:12267-12271.
17. 17. LIM SK, BIEKER JJ, LIN CS, COSTANTINI F. A shortened life span of EKLF -/- adult erythrocytes, due to a deficiency of beta-globin chains, is ameliorated by human gamma-globin chains. Blood 1997;90:1291-1299.
18. 18. CHIN K, ODA N, SHEN K, NOGUCHI CT. Regulation of transcription of the human erythropoietin receptor gene by proteins binding to GATA-1 and Sp1 motifs. Nucleic Acids Res 1995;23:3041-3049.
19. 19. CHENG T, SHEN H, GIOKAS D, GERE J, TENEN DG, SCADDEN DT. Temporal mapping of gene expression levels during the differentiation of individual primary hematopoietic cells. Proc Natl Acad Sci USA 1996;93:13158-13163.
20. 20. LABBAYE C, VALTIERI M, BARBERI T, et al. Differential expression and functional role of GATA-2, NF-E2, and GATA-1 in normal adult hematopoiesis. J Clin Invest 1995:95:2346-2358.
21. 21. FIBACH E, MANOR D, OPPENHEIM A, RACHMILEWITZ EA. Proliferation and maturation of human erythroid progenitors in liquid culture. Blood 1989;73:100-103.
22. 22. FIBACH E, RACHMILEWITZ EA. The two-step liquid culture: a novel procedure for studying maturation of human normal and pathological erythroid precursors. Stem Cells 1993; 11:36-41.
23. 23. LOZZIO CB, LOZZIO BB. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 1975;45:321-334.
24. 24. RUTHERFORD TR, CLEGG JB, WEATHERALL DJ. K562 human leukaemic cells synthesise embryonic haemoglobin in response to haemin. Nature 1979;280:164-165.
25. 25. FORDIS CM, ANAGNOU NP, DEAN A, NIENHUIS AW, SCHECHTER AN. A beta-globin gene, inactive in the K562 leukemic cell, functions normally in a heterologous expression system. Proc Natl Acad Sci USA 1984;81:4485-4489.
26. 26. MARKS PA, RIFKIND RA. Erythroleukemic differentiation. Annu Rev Biochem 1978;47:419-448.
27. 27. RASBAND W. NIHI Image (version 1.57).
28. 28. Snedecor. Statistical Methods. Iowa State University: Ames, 1980.
29. 29. TSAI FY, ORKIN SH. Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Blood 1997;89:3636-3643.
30. 30. DAYLOT N, FIBACH E, RACHMILEWITZ EA, OPPENHEIM A. Adult and neonatal patterns of human globin gene expression are recapitulated in liquid cultures. Exp Hematol 1992; 20:1141-1145.
31. 31. MALIK P, FISHER TC, BARSKY LLW, et al. An in vitro model of human red blood cell production from hematopoietic progenitor cells. Blood 1998;91:2664-2671.
32. 32. SU W, PORTER S, KUSTU S, ECHOLS H. DNA-looping and enhancer activity: association between DNA-bound NtrC activator and RNA polymerase at the bacterial glnA promoter. Proc Natl Acad Sci USA 1990;87:5504-5508.
33. 33. LI R, KNIGHT JD, JACKSON SP, TJIAN R, BOTCHAN MR. Direct interaction between Sp1 and the BPV enhancer E2 protein mediates synergistic activation of transcription. Cell 1991;65:493-505.
34. 34. PEVNY L, SIMON MC, ROBERTSON E, et al. Erythroid differentiation in chimaeric 1991;349:257-260.
35. 35. SIMON MC, PEVNY L, WILES MV, KELLER G, COSTANTINI F, ORKIN SH. Rescue of erythroid development in gene targeted GATA-1-mouse embryonic stem cells. Nat Genet 1992;1 92-98.
36. 36. WEISS MJ, YU C, ORKIN SH. Erythroid-cell-specific properties of transcription factor GATA-1 revealed by phenotypic rescue of a gene-targeted cell line. Mol Cell Biol 1997;17: 1642-1651.
37. 37. CROSSLEY M, MERIKA M, ORKIN SH. Self-association of the erythroid transcription factor GATA-1 mediated by its zinc finger domains. Mol Cell Biol 1995;15:2448-2456.
38. 38. RAICH N, CLEGG CH, GROFTI J, ROMEO PH, STAMATOYANNOPOULOS G. GATA1 and YY1 are developmental repressers of the human epsilon-globin gene. Embo J 1995;14:801-809.
39. 39. D'ANDREA AD, FASMAN GD, LODISH HF. Erythropoietin receptor and interleukin-2 receptor beta chain: a new receptor family. Cell 1989;58:1023.
40. 40. CARROLL MC, ZHU Y, D'ANDREA AD. Erythropoietin-induced cellular differentiation requires prolongation of the G1 phase of the cell cycle. Proc Natl Acad Sci USA 1995;92:2869-2873.
41. 41. YOUSSOUFIAN H, LONGMORE G, NEUMANN D, YOSHIMURA A, LODISH HF. Structure, function and activation of the erythropoietin receptor. Blood 1993;81:2223-2236.
42. 42. LIN CS, LIM SK, D'AGATI V, COSTANTINI F. Differential effects of an erythropoietin receptor gene disruption on prim-itive and definitive erythropoiesis. Genes Dev 1996;10:154-164.
43. 43. CHEE M, YANG R, HUBBELL E, et al. Accessing genetic information with high-density DNA arrays. Science 1996;274:610-614.
44. 44. HACIA JG, BRODY LC, CHEE MS, FODOR SP, COLLINS FS. Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two-colour fluorescence analysis. Nat Genet 1996;14:441-447.
45. 45. VELCULESCU VE, ZHANG L, VOGELSTEIN B, KINZLER KW. Serial analysis of gene expression [see comments]. Science 1995:270:484-487.
46. 46. PRIVITERA E, SCHIRO R, LONGONI D, et al. Constitutive expression of GATA-1, EPOR, alpha-globin, and gamma-globin genes in myeloid clonogenic cells from juvenile chronic myelocytic leukemia. Blood 1995;86:323-328.
47. 47. BIEKER JJ. Personal communication. 1995.
48. 48. BIEKER JJ. Personal communication. 1996.
49. 49. WINARDI R, REID M, CONBOY J, MOHANDAS N. Molecular analysis of glycophorin C deficiency in human erythrocytes. Blood 1993;81:2799-2830.